Search

Bennett C Borer

from San Diego, CA
Age ~61
Get Report
Also known as:
Ben Borer, Borer Ben, Borer Bennett, Chaplin Borer Bennett
Phone and address:
4149 Lymer Dr, San Diego, CA 92116
(858) 717-1242
Related to:
Brett D Goldman, 25Lloyd C Borer, 89Elisabeth HansenSusan E Kephart, 56Janice G Borer, 88Alan B Borer, 62Robert W Hansen, 86George A Kephart, 55Clara M Borer, 59Daniel R Hansen, 57Barbara D Hansen, 60
Connected to:
Andrea L Borer, 41Emma G Borer, 35Kari C Borer, 61Kevin M Borer, 43Patricia A Borer, 73Shannon D Borer, 44Thomas L Borer, 57Tristan A Borer, 59Dean K Borero, 39Gerald A Bores, 70

Bennett Borer Phones & Addresses

  • 4149 Lymer Dr, San Diego, CA 92116 (858) 717-1242
  • La Jolla, CA
  • Tiffin, OH
  • Bowling Green, OH
  • Indianapolis, IN
  • 192 Saint Francis Ave APT 22, Tiffin, OH 44883

Publications

Us Patents

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
6392067, May 21, 2002
Filed:
May 21, 2001
Appl. No.:
09/859368
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
Japan Tobacco Inc. - Osaka
International Classification:
C07C24704
US Classification:
552 10, 549 34
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Methods For The Preparation Of Intermediates In The Synthesis Of Hiv-Protease Inhibitors

View page
US Patent:
6403799, Jun 11, 2002
Filed:
Oct 17, 2000
Appl. No.:
09/690093
Inventors:
Bennett C. Borer - La Jolla CA
Scott E. Zook - San Diego CA
Juliette K. Busse - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
International Classification:
C07D21706
US Classification:
546146, 514307
Abstract:
Methods for the preparation of chemical intermediates in the synthesis of HIV-protease inhibitors related to and including nelfinavir mesylate are disclosed. The method of this invention comprises converting tetrohydran derivatives into oxazolines to provide key reaction intermediates for the preparation of nelfinavir. Also disclosed is a method for the preparation of a chiral amino alcohol from an epoxy-tetrahydrofuran.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
6465661, Oct 15, 2002
Filed:
Mar 21, 2002
Appl. No.:
10/101858
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - La Jolla CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - San Diego CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
International Classification:
C07D20902
US Classification:
548473, 558 47
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Methods For The Preparation Of Intermediates In The Synthesis Of Hiv-Protease Inhibitors

View page
US Patent:
6472534, Oct 29, 2002
Filed:
Nov 7, 2001
Appl. No.:
09/986146
Inventors:
Bennett C. Borer - La Jolla CA
Scott E. Zook - San Diego CA
Juliette K. Busse - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
International Classification:
C07D26308
US Classification:
548237, 548239
Abstract:
Methods for the preparation of chemical intermediates in the synthesis of HIV-protease inhibitors related to and including nelfinavir mesylate are disclosed. The method of this invention comprises converting tetrohydran derivatives into oxazolines to provide key reaction intermediates for the preparation of nelfinavir. Also disclosed is a method for the preparation of a chiral amino alcohol from an epoxy-tetrahydrofuran.

Polymorphic And Amorphous Forms Of The Phosphate Salt Of 8-Fluoro-2-{4-[(Methylamino)Methyl]Phenyl}-1,3,4,5-Tetrahydro-6H-Azepino[5,4,3-Ce]Indol-6-One

View page
US Patent:
7268126, Sep 11, 2007
Filed:
Sep 21, 2005
Appl. No.:
11/233835
Inventors:
Jia Liu - San Diego CA, US
Naresh Nayyar - San Diego CA, US
Ming Guo - San Diego CA, US
Bennett Chaplin Borer - San Diego CA, US
Aparna Nadig Srirangam - San Diego CA, US
Mark Bryan Mitchell - San Diego CA, US
Yi Li - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
Cancer Research Technology Ltd. - London
International Classification:
C07D 487/06
A61K 31/55
A61P 35/00
A61P 35/28
US Classification:
51421204, 540520
Abstract:
The present invention relates to novel polymorphic and amorphous forms of a phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.

Methods For The Preparation Of Intermediates In The Synthesis Of Hiv-Protease Inhibitors

View page
US Patent:
20030023092, Jan 30, 2003
Filed:
Aug 26, 2002
Appl. No.:
10/227402
Inventors:
Bennett Borer - La Jolla CA, US
Scott Zook - San Diego CA, US
Juliette Busse - San Diego CA, US
International Classification:
C07D413/04
C07D263/08
US Classification:
546/271400, 548/237000
Abstract:
Methods for the preparation of chemical intermediates in the synthesis of HIV-protease inhibitors related to and including nelfinavir mesylate are disclosed. The method of this invention comprises converting tetrohydran derivatives into oxazolines to provide key reaction intermediates for the preparation of nelfinavir. Also disclosed is a method for the preparation of a chiral amino alcohol from an epoxy-tetrahydrofuran.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
63166259, Nov 13, 2001
Filed:
Jul 21, 2000
Appl. No.:
9/621681
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
Japan Tobacco Inc. - Tokyo
International Classification:
C07D21706
A61K 3147
US Classification:
546146
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
6117999, Sep 12, 2000
Filed:
Feb 19, 1999
Appl. No.:
9/252802
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Phramaceuticals, Inc. - La Jolla CA
Japan Tobacco, Inc. - Tokyo
International Classification:
C07D21716
US Classification:
546146
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.
Control profile
Bennett C Borer from San Diego, CA, age ~61 Get Report